TXG:NSD-10X Genomics Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 9.53

Change

+0.20 (+2.09)%

Market Cap

N/A

Volume

4.65M

Analyst Target

USD 120.25
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-30 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

N/A

USD 33.49B
TEM Tempus AI, Inc. Class A Common..

N/A

USD 9.87B
HQY HealthEquity Inc

N/A

USD 7.83B
WAY Waystar Holding Corp. Common S..

N/A

USD 6.42B
BTSG BrightSpring Health Services, ..

N/A

USD 4.26B
PRVA Privia Health Group Inc

N/A

USD 2.79B
CERT Certara Inc

N/A

USD 1.94B
PINC Premier Inc

N/A

USD 1.93B
SDGR Schrodinger Inc

N/A

USD 1.57B
GDRX Goodrx Holdings Inc

N/A

USD 1.55B

ETFs Containing TXG

ZSG0:XETRA 4.36 % 0.00 %

N/A

N/A
ESGO:PA AuAg ESG Gold Mining UCIT.. 4.36 % 0.00 %

N/A

N/A
ESGO:LSE AuAg ESG Gold Mining UCIT.. 4.31 % 0.00 %

N/A

USD 0.02B
ZGD:CA BMO Equal Weight Global G.. 2.81 % 0.61 %

N/A

CAD 0.13B
CGV Two Roads Shared Trust 2.11 % 0.00 %

N/A

USD 0.11B
FDTS First Trust Developed Mar.. 0.00 % 0.80 %

N/A

USD 6.47M
GOEX Global X Gold Explorers E.. 0.00 % 0.65 %

N/A

USD 0.06B
PZC:CA 0.00 % 0.67 %

N/A

N/A
XCS:CA iShares S&P/TSX Small Cap 0.00 % 0.61 %

N/A

CAD 0.15B
GOAU U.S. Global GO GOLD and P.. 0.00 % 0.60 %

N/A

USD 0.11B
UBUD:XETRA UBS (Irl) ETF plc - Solac.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -33.64% 20% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -33.64% 20% F 21% F
Trailing 12 Months  
Capital Gain -57.49% 22% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -57.49% 22% F 16% F
Trailing 5 Years  
Capital Gain -87.78% 30% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -87.78% 30% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain -26.03% 22% F 10% F
Dividend Return -26.03% 22% F 10% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 52.79% 36% F 34% F
Risk Adjusted Return -49.31% 34% F 16% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector